Jazz Pharmaceuticals plc buy Barclays PLC
Start price
29.01.24
/
50%
€116.60
Target price
29.01.25
€217.33
Performance (%)
-10.03%
Price
30.08.24
€104.90
Summary
This prediction is currently active. The prediction for Jazz Pharmaceuticals plc disappoints with a performance of -10.03%. This prediction currently runs until 29.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 3.147% | 3.147% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Barclays_PLC for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $240.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Barclays_PLC for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€102.25
03.05.24
03.05.24
€185.60
03.05.25
03.05.25
2.59%
30.08.24
30.08.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.55
01.03.24
01.03.24
€212.20
01.03.25
01.03.25
-4.24%
30.08.24
30.08.24